Advertisement

Pharmacy World & Science

, Volume 29, Issue 4, pp 395–399 | Cite as

Topical corticosteroids in infants: prescribing pattern and prescribing errors in Bahrain

  • Khalid A. J. Al KhajaEmail author
  • Awatif H. H. Damanhori
  • Thuraya M. Al-Ansari
  • Reginald P. Sequeira
Original Paper

Abstract

Objective

A nationwide, primary care-based prescription audit in infants to determine the prescribing pattern and prescribing errors of topical corticosteroid preparations in Bahrain.

Method

Prescriptions dispensed for infants were collected for two successive weeks from 20 primary-care health centres.

Results

Among 2282 out of 102,084 prescriptions (2.2%) dispensed for infants, 296 (13.0%) had corticosteroids for topical application to the skin, eye and ear. Plain corticosteroids comprised 6.7%, whereas corticosteroids with antiinfectives accounted for 6.3% of topical corticosteroid preparations. Based on potency the proportions of corticosteroids prescribed were: mild (6.7%), moderately potent (2.6%) and potent (3.7%). The frequency of dosing and length of therapy were not stated in 21.6% and 43.6% of prescriptions, respectively. Base cream as a dilutional vehicle was prescribed in 11.2% (11/98) and 32.4% (12/37) prescriptions containing hydrocortisone acetate 1% cream and betamethasone valerate 0.1%, respectively. In few instances two corticosteroids were concomitantly prescribed.

Conclusion

Prescribing moderate-to-potent topical preparations in approximately half of the infants, co-prescription of multiple corticosteroid preparations, omission of important components of prescription, and resorting to the controversial vehicle diluting technique suggest that topical corticosteroid therapy is sub-optimal. In infants, topical corticosteroids should be rationally prescribed. Establishing the treatment guidelines, pharmacovigilance programme and revision of the primary care essential drug list are needed in Bahrain.

Keywords

Topical corticosteroids Infants Prescribing pattern Prescribing errors Primary care Middle East Bahrain 

Notes

Acknowledgments

We acknowledge the help and assistance given to us by the Ministry of Health, Directorate of Health Centres/Primary Health Care: Dr. Awatif S. Sharaf (Chief of Medical Services for Primary-Care Health Centres); Dr. Bahyia Al Assoomi (Deputy Chief of Medical Services); the pharmacists and the pharmacy technicians of all health centres; Moh’d Ghali Rashid from Medical Library for information retrieval; and Radha Raghavan for her help in manuscript preparation.

Conflicts of interest

None declared.

References

  1. 1.
    Knowles SR, Wong G, Shear NH. Dermatological drugs, topical agents and cosmetics. In: Aronson JK, editor. Side Effects of Drugs Annual-28. Amsterdam: Elsevier; 2005. ISBN 0-444-51571-2Google Scholar
  2. 2.
    British National Formulary (BNF) (# 50) 2005, Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    Wyatt EL, Sutter SH, Drake LA. Dermatological Pharmacology. In: Hardman JG, Limbird LE, editors. Goodman & Gilmans’ The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw Hill; 2001. ISBN 0-07-135469-7. Google Scholar
  4. 4.
    Martindale. The Complete Drug Reference. 33rd ed. Great Britain: Pharmaceutical Press; 2002. ISBN 0 85369 499 0Google Scholar
  5. 5.
    Al Khaja KAJ, Al-Ansari TM, Sequeira RP. An evaluation of prescribing errors in primary care in Bahrain. Intl J Clin Pharmacol Therap 2005; 43(6):294–301Google Scholar
  6. 6.
    Santer M, Lewis-Jones S, Fahey T. Appropriateness of prescribing for childhood eczema: evidence from a community-based study. Clin Exper Dermatol 2006; 31(5):671–73. CrossRefGoogle Scholar
  7. 7.
    Kizu J, Ichihara W, Tomonaga E, et al. Survey of mixing commercially available corticosteroid ointment with other ointments and the anti-inflammatory activity of the admixtures. Yakugaku Zasshi 2004; 124(2):93–97PubMedCrossRefGoogle Scholar
  8. 8.
    Guin JD, Wallis MS, Walls R, et al. Quantitative vasoconstrictor assay for topical corticosteroids: the puzzling case of fluocinolone acetonide. J Am Acad Dermatol 1993; 29(2pt1):197–202PubMedGoogle Scholar
  9. 9.
    Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology. J Am Acad Dermatol 1996; 35(4):615–19PubMedCrossRefGoogle Scholar
  10. 10.
    Chung I, Buhr V. Topical ophthalmic drugs and the pediatric patient. Optometry 2000; 71(8):511–18PubMedGoogle Scholar
  11. 11.
    Cabana M, Rand C, Powe N, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282(15):1458–65PubMedCrossRefGoogle Scholar
  12. 12.
    Lexchin J. Improving the appropriateness of physician prescribing. Intl J Health Serv 1998; 28(2):253–67Google Scholar
  13. 13.
    Thomson O’Brien MA, Freemantle N, Oxman AD, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2001; 2:CD 003030Google Scholar
  14. 14.
    Worall G, Chaulk P, Freake D. The effects of clinical practice guidelines on patient outcome in primary care: a systematic review. J Canad Med Assoc 1997; 156(12):1705–12. Google Scholar
  15. 15.
    Bradley C. Uncomfortable prescribing decisions: critical incident study. BMJ 1992; 304(6822):1294–96CrossRefGoogle Scholar
  16. 16.
    Paredes P, de la Pena M, Flores-Guerra E, et al. Factors influencing physicians’ prescribing behaviour in the treatment of childhood diarrhea: knowledge may not be the clue. Soc Sci Med 1996; 42(8):1141–53PubMedCrossRefGoogle Scholar
  17. 17.
    Levine M, Cosby J. Valuing knowledge and knowledge values: understanding guideline-incongruent prescribing. J Clin Pharmacol 2002; 42(5):475–76PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Khalid A. J. Al Khaja
    • 1
    Email author
  • Awatif H. H. Damanhori
    • 2
  • Thuraya M. Al-Ansari
    • 2
  • Reginald P. Sequeira
    • 1
  1. 1.Department of Pharmacology and TherapeuticsArabian Gulf UniversityManamaKingdom of Bahrain
  2. 2.Primary CareMinistry of HealthManamaKingdom of Bahrain

Personalised recommendations